These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 15362211)

  • 1. [Guideline for appropriate use of radioactive medicine].
    Kaku Igaku; 2004 May; 41(2):3-58. PubMed ID: 15362211
    [No Abstract]   [Full Text] [Related]  

  • 2. Handling of radioactive seed localization breast specimens in the pathology laboratory.
    Graham RP; Jakub JW; Brunette JJ; Reynolds C
    Am J Surg Pathol; 2012 Nov; 36(11):1718-23. PubMed ID: 23060351
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Current techniques and procedures in nuclear medicine].
    Domènech Torné FM
    Med Clin (Barc); 2010 May; 134(13):589-90. PubMed ID: 19819492
    [No Abstract]   [Full Text] [Related]  

  • 4. Outcomes assessment and disease management strategies in diagnostic imaging: creating value and quality with nuclear cardiology.
    Shaw LJ; Hachamovitch R; Thomas G
    J Cardiovasc Manag; 1998; 9(5):10-8. PubMed ID: 10185107
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protection of the patient in nuclear medicine.
    Ann ICRP; 1987; 17(4):1-37. PubMed ID: 3324842
    [No Abstract]   [Full Text] [Related]  

  • 6. Calculations in nuclear medicine--application of free online software.
    Swiętaszczyk C; Pilecki SE
    Nucl Med Rev Cent East Eur; 2013; 16(2):103-8. PubMed ID: 24068645
    [No Abstract]   [Full Text] [Related]  

  • 7. How the ASNC ImageGuide Registry will guide healthcare policy.
    Williams KA; McKinley AP;
    J Nucl Cardiol; 2013 Oct; 20(5):948-50. PubMed ID: 23959826
    [No Abstract]   [Full Text] [Related]  

  • 8. Handling of radioactive seed localisation breast specimens in the histopathology laboratory: the Western Australian experience.
    Dessauvagie BF; Frost FA; Sterrett GF; Hardie M; Parry J; Latham B; Westcott E; Rourke T; Burrage J; Bourke A; Taylor D; Kamyab R; Saunders C
    Pathology; 2015 Jan; 47(1):21-6. PubMed ID: 25485655
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nuclear medicine.
    Ell PJ
    Postgrad Med J; 1992 Feb; 68(796):82-105. PubMed ID: 1570267
    [No Abstract]   [Full Text] [Related]  

  • 10. Radioactive isotopes in clinical medicine and research. 22nd International symposium. Badgastein, Austria, January 9-12, 1996. Abstracts.
    Eur J Nucl Med; 1996 Jan; 23(1):S1-30. PubMed ID: 8586093
    [No Abstract]   [Full Text] [Related]  

  • 11. Is nuclear medicine cost-effective?
    Ripley S
    Dimens Health Serv; 1991 Mar; 68(2):21-3. PubMed ID: 1903114
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sentinel lymph node biopsy and melanoma: 2010 update Part I.
    Stebbins WG; Garibyan L; Sober AJ
    J Am Acad Dermatol; 2010 May; 62(5):723-34; quiz 735-6. PubMed ID: 20398810
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Modern diagnostics in breast cancer: nuclear medicine techniques].
    Borbély K; Sinkovics I; Madaras B; Horváth Z; Láng I; Kásler M
    Orv Hetil; 2012 Jan; 153(1):14-21. PubMed ID: 22204830
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Nuclear medicine procedures in paediatric patients].
    Alaoui NI; Sergent-Alaoui A; de Labriolle-Vaylet C
    Rev Prat; 2012 Feb; 62(2):161-6. PubMed ID: 22408851
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predictive role of imaging in sentinel lymph node dissection for melanoma.
    Ho AM; Avery R; Krupinski EA; Warneke J; Kuo PH
    Lymphology; 2014 Sep; 47(3):134-41. PubMed ID: 25420306
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A defining moment: Nuclear medicine, molecular imaging, SNM.
    Sandler MP
    J Nucl Med; 2006 Jul; 47(7):36N, 37N. PubMed ID: 16871699
    [No Abstract]   [Full Text] [Related]  

  • 17. Cost-effectiveness analysis in nuclear medicine.
    Gambhir SS
    J Nucl Med; 1998 Jan; 39(1):17N-18N. PubMed ID: 9443723
    [No Abstract]   [Full Text] [Related]  

  • 18. Localizing non-palpable breast lesions: the subtleties of selecting the right method.
    Spillane A
    ANZ J Surg; 2015; 85(7-8):497-8. PubMed ID: 26735616
    [No Abstract]   [Full Text] [Related]  

  • 19. Nuclear medicine practitioners evaluate their cost-effectiveness.
    Miller L
    J Nucl Med; 1994 Feb; 35(2):13N-14N, 17N. PubMed ID: 8294981
    [No Abstract]   [Full Text] [Related]  

  • 20. [Evidence-based nuclear medicine and experience-based nuclear medicine].
    Carreras Delgado JL
    An R Acad Nac Med (Madr); 2000; 117(3):625-49; discussion 649-54. PubMed ID: 11205044
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.